Friday 6 November 2026 Export RYTM’s income statement to Excel — free account

Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $189.8 million, up 45.8% from fiscal 2024.

Revenue: +79.6%
EPS: +26.9%
Free cash flow: +95.4%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

112.38 7.36 +7.01%

Follow RYTM

Alert me

Market cap: $7.3B
P/E: 0.0×
Fwd P/E: −31.6×
Dividend yield: —
F-score: 6/9
Altman Z: 15.89
Beneish M: −2.93
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Rhythm Pharmaceuticals, Inc. (RYTM) P/E ratio

Alert me on P/E ratio

Rhythm Pharmaceuticals, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RYTM/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Rhythm Pharmaceuticals, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RYTM/metrics/pe-ratio">Rhythm Pharmaceuticals, Inc. (RYTM) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—

Period	P/E ratio	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
19 more quarters	Free account

Against its own ten years

Low 0.0× High 0.0×

Ten-year median 0.0×

Current reading's percentile 100

Company	P/E ratio
ABVX Abivax SA Sponsored ADR compare	n/m
PRAX Praxis Precision Medicines, Inc. compare	n/m
CYTK Cytokinetics, Incorporated compare	n/m
AXSM Axsome Therapeutics, Inc. compare	n/m
IONS Ionis Pharmaceuticals, Inc. compare	n/m
ARWR Arrowhead Pharmaceuticals, Inc. compare	n/m
ORKA Oruka Therapeutics, Inc. compare	n/m
RYTM Rhythm Pharmaceuticals, Inc.	n/m
CORT Corcept Therapeutics Incorporated compare	47.5×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Rhythm Pharmaceuticals, Inc. (RYTM) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on RYTM

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on RYTM

Stockrow Weekly